Peptic ulcer disease today
作者： Yuhong Yuan , Ireneusz T Padol , Richard H Hunt
关键词: Intensive care medicine 、 Risk assessment 、 Drug 、 Antibiotics 、 Internal medicine 、 Gastroenterology 、 Medicine 、 Helicobacter pylori 、 Therapeutic approach 、 Disease 、 Peptic 、 Aspirin
摘要: … and NSAIDs are independent risk factors for peptic ulcer … of NSAID use and their ongoing use of aspirin or NSAIDs … genetic factors that predict the development of idiopathic ulcers…
nature.com
ptolemy.ca 参考文章(74)
Amnon Sonnenberg, Geographic and temporal variations in the occurrence of peptic ulcer disease. Scandinavian Journal of Gastroenterology. ,vol. 110, pp. 11- 24 ,(1985) , 10.3109/00365528509095826
Alexander C Ford, Michelle Qume, Paul Moayyedi, Nicolaas LA Arents, Annmarie T Lassen, Richard FA Logan, Kenneth EL McColl, Paul Myres, Brendan C Delaney, None, Helicobacter pylori “Test and Treat” or Endoscopy for Managing Dyspepsia: An Individual Patient Data Meta-analysis Gastroenterology. ,vol. 128, pp. 1838- 1844 ,(2005) , 10.1053/J.GASTRO.2005.03.004
Carolyn Quan, Nicholas J. Talley, Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. The American Journal of Gastroenterology. ,vol. 97, pp. 2950- 2961 ,(2002) , 10.1111/J.1572-0241.2002.07068.X
Thomas J Schnitzer, Gerd R Burmester, Eduardo Mysler, Marc C Hochberg, Michael Doherty, Elena Ehrsam, Xavier Gitton, Gerhard Krammer, Bernhard Mellein, Patrice Matchaba, Alberto Gimona, Christopher J Hawkey, None, Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. The Lancet. ,vol. 364, pp. 665- 674 ,(2004) , 10.1016/S0140-6736(04)16893-1
Jia-Qing Huang, Subbaramiah Sridhar, Richard H Hunt, Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. The Lancet. ,vol. 359, pp. 14- 22 ,(2002) , 10.1016/S0140-6736(02)07273-2
L S Lohmander, A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis. Annals of the Rheumatic Diseases. ,vol. 64, pp. 449- 456 ,(2004) , 10.1136/ARD.2004.023572
Steven M. Weisman, David Y. Graham, Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. JAMA Internal Medicine. ,vol. 162, pp. 2197- 2202 ,(2002) , 10.1001/ARCHINTE.162.19.2197
Grigoris I Leontiadis, Virender K Sharma, Colin W Howden, Systematic Review and Meta-Analysis of Proton Pump Inhibitor Therapy in Peptic Ulcer Bleeding BMJ. ,vol. 330, pp. 568- 568 ,(2005) , 10.1136/BMJ.38356.641134.8F
R. W. Dubois, G. Y. Melmed, J. M. Henning, L. Laine, Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Alimentary Pharmacology & Therapeutics. ,vol. 19, pp. 197- 208 ,(2004) , 10.1111/J.0269-2813.2004.01834.X
M. A. Perez-Aisa, D. Del Pino, M. Siles, A. Lanas, Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. ,vol. 21, pp. 65- 72 ,(2005) , 10.1111/J.1365-2036.2004.02297.X